Stephen A. Boorjian
Mayo Clinic in Arizona, Fox Chase Cancer Center, Cornell University, Mayo Clinic
Papers
28
Total Citations
1,151
H-Index
15
About
Stephen A. Boorjian is a prominent urologic oncologist and surgeon-scientist whose work has fundamentally shaped the evidence base for treating urological cancers, particularly prostate, bladder, and kidney malignancies. Based at the Mayo Clinic, Boorjian has made landmark contributions through rigorous outcomes research and comparative effectiveness studies. His critical long-term analysis of radical prostatectomy's impact on cancer control and functional outcomes (236 citations) remains a cornerstone reference for clinicians counseling prostate cancer patients. His investigations into robot-assisted surgical techniques — spanning partial nephrectomy, radical cystectomy, and prostatectomy — have helped define the risks, benefits, and appropriate indications for minimally invasive approaches. A recurring theme in his research is health equity: his work exposing socioeconomic disparities in access to robotic surgery highlights systemic inequities in cancer care delivery. Earlier in his career, Boorjian contributed meaningfully to male reproductive medicine, including influential research on vasectomy reversal outcomes. With multiple papers accumulating hundreds of citations and contributions to systematic reviews informing clinical guidelines, his scholarship has profoundly influenced both surgical practice and health policy in urology worldwide.
Research Focus
Key Achievements
Top Papers
- 1
- 2Robot-assisted Partial Nephrectomy: A Large Single-institutional Experience141 citations · 2010
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10